COSMECCA KOREA CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48,400 KRW | -1.93% |
|
+10.00% | +33.33% |
| 2023 | Cosmecca Korea Co., Ltd.(KOSDAQ:A241710) added to S&P Global BMI Index | CI |
| 2023 | Cosmecca Korea Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 121,218 | 130,296 | 138,306 | 109,470 | 387,684 | 516,912 | - | - |
| Enterprise Value (EV) 2 | 207.1 | 215.7 | 230.6 | 109.5 | 455.8 | 562 | 521.7 | 487.9 |
| P/E ratio | 42.8 x | 49.8 x | 15.5 x | 41.2 x | 17.4 x | 14.4 x | 12.7 x | 9.6 x |
| Yield | 0.88% | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.35 x | 0.38 x | 0.35 x | 0.27 x | 0.82 x | 0.95 x | 0.84 x | 0.74 x |
| EV / Revenue | 0.6 x | 0.64 x | 0.58 x | 0.27 x | 0.97 x | 1.03 x | 0.84 x | 0.7 x |
| EV / EBITDA | 8.98 x | 9.16 x | 6.82 x | 4.04 x | 6.91 x | 6.81 x | 5.48 x | 4.32 x |
| EV / FCF | -19.6 x | -93.2 x | -211 x | - | 19.5 x | 24.6 x | 14.4 x | 12.2 x |
| FCF Yield | -5.09% | -1.07% | -0.47% | - | 5.13% | 4.06% | 6.92% | 8.2% |
| Price to Book | 0.95 x | 1 x | 0.97 x | 0.75 x | 2.29 x | 2.52 x | 2.1 x | 1.68 x |
| Nbr of stocks (in thousands) | 10,680 | 10,680 | 10,680 | 10,680 | 10,680 | 10,680 | - | - |
| Reference price 3 | 11,350 | 12,200 | 12,950 | 10,250 | 36,300 | 48,400 | 48,400 | 48,400 |
| Announcement Date | 2/27/20 | 3/18/21 | 2/23/22 | 2/23/23 | 2/23/24 | - | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 347.1 | 339.1 | 396.5 | 399.4 | 470.7 | 546.3 | 618.3 | 697.3 |
| EBITDA 1 | 23.05 | 23.54 | 33.82 | 27.09 | 65.93 | 82.5 | 95.16 | 113 |
| EBIT 1 | 8.301 | 9.903 | 20.1 | 10.37 | 49.16 | 65.78 | 78.84 | 91 |
| Operating Margin | 2.39% | 2.92% | 5.07% | 2.6% | 10.44% | 12.04% | 12.75% | 13.05% |
| Earnings before Tax (EBT) 1 | 6.291 | 4.336 | 17.51 | 6.373 | 46.11 | 66.93 | 78.44 | 100.2 |
| Net income 1 | 2 | 2.622 | 8.912 | 2.656 | 22.07 | 35.7 | 40.7 | 53.85 |
| Net margin | 0.58% | 0.77% | 2.25% | 0.67% | 4.69% | 6.53% | 6.58% | 7.72% |
| EPS 2 | 265.0 | 245.0 | 834.0 | 249.0 | 2,090 | 3,351 | 3,806 | 5,044 |
| Free Cash Flow 3 | -10,547 | -2,314 | -1,091 | - | 23,400 | 22,833 | 36,125 | 40,000 |
| FCF margin | -3,039.1% | -682.53% | -275.22% | - | 4,971.13% | 4,179.63% | 5,842.44% | 5,736.41% |
| FCF Conversion (EBITDA) | - | - | - | - | 35,494.61% | 27,676.77% | 37,962.38% | 35,382.57% |
| FCF Conversion (Net income) | - | - | - | - | 106,036.12% | 63,958.92% | 88,759.21% | 74,280.41% |
| Dividend per Share | 100.0 | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 3/18/21 | 2/23/22 | 2/23/23 | 2/23/24 | - | - | - |
1KRW in Billions2KRW3KRW in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 93.72 | 89 | 100.4 | 103.5 | 106.4 | - | 116.4 | 122.7 | 125.6 | 134.3 | 141.4 | 142.7 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 1.39 | 0.612 | 3.061 | 2.936 | 3.758 | - | 13.7 | 15.04 | 13.73 | 15.73 | 17.43 | 18.6 |
| Operating Margin | 1.48% | 0.69% | 3.05% | 2.84% | 3.53% | - | 11.77% | 12.26% | 10.93% | 11.72% | 12.33% | 13.03% |
| Earnings before Tax (EBT) 1 | -0.0598 | 0.403 | - | - | -2.331 | - | - | 10.72 | 16.31 | 15.2 | 17.2 | 16 |
| Net income 1 | 1.265 | -0.023 | 1.719 | - | - | 5.914 | 7.276 | 4.405 | 8.788 | 8.8 | 8.95 | 7.85 |
| Net margin | 1.35% | -0.03% | 1.71% | - | - | - | 6.25% | 3.59% | 7% | 6.55% | 6.33% | 5.5% |
| EPS | - | - | - | - | - | 554.0 | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/23/22 | 5/6/22 | 8/5/22 | 11/4/22 | 2/23/23 | 8/14/23 | 11/6/23 | 2/23/24 | 5/10/24 | - | - | - |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 85.9 | 85.4 | 92.3 | - | 68.2 | 45.1 | 4.83 | - |
| Net Cash position 1 | - | - | - | - | - | - | - | 29 |
| Leverage (Debt/EBITDA) | 3.725 x | 3.628 x | 2.73 x | - | 1.034 x | 0.5471 x | 0.0507 x | - |
| Free Cash Flow 2 | -10,547 | -2,314 | -1,091 | - | 23,400 | 22,833 | 36,125 | 40,000 |
| ROE (net income / shareholders' equity) | 1.17% | 2.04% | 6.55% | 2.98% | 14.1% | 19.1% | 18% | 19.2% |
| ROA (Net income/ Total Assets) | 0.6% | 0.74% | 2.37% | 0.68% | 5.41% | 7.8% | 9.2% | 8.3% |
| Assets 1 | 332.2 | 354.9 | 375.6 | 392.2 | 408 | 457.7 | 442.4 | 648.8 |
| Book Value Per Share 3 | 11,958 | 12,150 | 13,319 | 13,732 | 15,874 | 19,237 | 23,073 | 28,884 |
| Cash Flow per Share 3 | 1,686 | - | 739.0 | - | 3,930 | 4,848 | 7,696 | 11,324 |
| Capex 1 | 28.6 | 14.2 | 8.98 | 11.6 | 18.6 | 17.7 | 18.5 | 17.5 |
| Capex / Sales | 8.23% | 4.2% | 2.26% | 2.9% | 3.94% | 3.24% | 2.99% | 2.51% |
| Announcement Date | 2/27/20 | 3/18/21 | 2/23/22 | 2/23/23 | 2/23/24 | - | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
48,400
KRW
Average target price
57,667
KRW
Spread / Average Target
+19.15%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +33.33% | 379M | |
| -0.73% | 260B | |
| +18.78% | 20.41B | |
| 0.00% | 19.12B | |
| +18.02% | 12.78B | |
| -15.06% | 9.11B | |
| +27.24% | 8.31B | |
| +9.08% | 5.91B | |
| -8.58% | 4.15B | |
| -17.45% | 3.81B |
- Stock Market
- Equities
- A241710 Stock
- Financials Cosmecca Korea Co., Ltd.
